Sage Journals: Discover world-class research

Retricted access

Research article

First published 2005-04

Selective Internal Radiation Therapy with SIR-Spheres ® in Patients with Nonresectable Liver Tumors

Gabriele Pöpperl, Thomas Helmberger, Wolfgang Münzing [...]

Cancer Biotherapy and Radiopharmaceuticals

Open access

Review article

First published 2019

SIR-Spheres ® Y-90 resin microspheres in chemotherapy refractory or intolerant patients with metastatic colorectal cancer

Silvia Coretti, Filippo Rumi, Dario Sacchini [...]

Global & Regional Health Technology Assessment: Italian;Northern Europe and Spanish

Free access

Research article

First published 2009-2

Treatment of Primary Liver Tumors with Yttrium-90 Microspheres (TheraSphere®) in High Risk Patients: Analysis of Survival and Toxicities

Kelli A. Reardon, Alyson F. McIntosh, A. Tanner Shilling [...]

Technology in Cancer Research & Treatment

Retricted access

Research article

First published 2015

Sir William Brooke O’Shaughnessy (1808–1889),MD,FRS,LRCS Ed: Chemical pathologist,pharmacologist and pioneer in electric telegraphy

Neil MacGillivray

Journal of Medical Biography

Retricted access

Research article

First published 2009-08

Y-90 Microsphere Therapy: Prevention of Adverse Events

Cheryl C. Schultz, Janice Campbell, Donovan Bakalyar [...]

Cancer Biotherapy and Radiopharmaceuticals

Retricted access

Research article

First published 2017-1

Campaigning for a community: Urdu literature of mobilisation and identity

Christina Oesterheld

The Indian Economic and Social History Review

Retricted access

Research article

First published 2025-05

Dosimetry Assessment in Predicting Treatment Outcomes Following Yttrium-90 Transarterial Radioembolization of Hepatic Tumors

Christina Ward, Sandon Scott, William Wesson [...]

Cancer Biotherapy and Radiopharmaceuticals

Search results

Selective Internal Radiation Therapy with SIR-Spheres ® in Patients with Nonresectable Liver Tumors

SIR-Spheres ® Y-90 resin microspheres in chemotherapy refractory or intolerant patients with metastatic colorectal cancer

Treatment of Primary Liver Tumors with Yttrium-90 Microspheres (TheraSphere®) in High Risk Patients: Analysis of Survival and Toxicities

Sir William Brooke O’Shaughnessy (1808–1889),MD,FRS,LRCS Ed: Chemical pathologist,pharmacologist and pioneer in electric telegraphy

Y-90 Microsphere Therapy: Prevention of Adverse Events

Campaigning for a community: Urdu literature of mobilisation and identity

Dosimetry Assessment in Predicting Treatment Outcomes Following Yttrium-90 Transarterial Radioembolization of Hepatic Tumors